A citation-based method for searching scientific literature

Georgios S Papaetis. World J Diabetes 2014
Times Cited: 18







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of prediabetes.
Mustafa Kanat, Ralph A DeFronzo, Muhammad A Abdul-Ghani. World J Diabetes 2015
39
22

Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
22

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
22

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
22

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
16

Prediabetes diagnosis and treatment: A review.
Nidhi Bansal. World J Diabetes 2015
158
16

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Abbas E Kitabchi, Marinella Temprosa, William C Knowler, Steven E Kahn, Sarah E Fowler, Steven M Haffner, Reuben Andres, Christopher Saudek, Sharon L Edelstein, Richard Arakaki,[...]. Diabetes 2005
317
16


The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.
Mustafa Kanat, Diedre Winnier, Luke Norton, Nazik Arar, Chris Jenkinson, Ralph A Defronzo, Muhammad A Abdul-Ghani. Diabetes Care 2011
48
16

Thiazolidinediones and type 2 diabetes: from cellular targets to cardiovascular benefit.
Georgios S Papaetis, Dora Orphanidou, Themistoklis N Panagiotou. Curr Drug Targets 2011
15
20

The incretin concept today.
W Creutzfeldt. Diabetologia 1979
654
16


Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.
Georgios S Papaetis, Panagiotis Papakyriakou, Themistoklis N Panagiotou. Arch Med Sci 2015
68
16

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
16




Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
11

Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance.
Mustafa Kanat, Andrea Mari, Luke Norton, Diedre Winnier, Ralph A DeFronzo, Chris Jenkinson, Muhammad A Abdul-Ghani. Diabetes 2012
75
11



Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study.
Julia Lamparter, Philipp Raum, Norbert Pfeiffer, Tunde Peto, René Höhn, Heike Elflein, Philipp Wild, Andreas Schulz, Astrid Schneider, Alireza Mirshahi. J Diabetes Complications 2014
43
11


Pioglitazone for diabetes prevention in impaired glucose tolerance.
Ralph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Howard N Hodis, Abbas E Kitabchi,[...]. N Engl J Med 2011
459
11

Neuropathy in prediabetes: does the clock start ticking early?
Nikolaos Papanas, Aaron I Vinik, Dan Ziegler. Nat Rev Endocrinol 2011
127
11

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
11

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
11

Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010.
Kai McKeever Bullard, Sharon H Saydah, Giuseppina Imperatore, Catherine C Cowie, Edward W Gregg, Linda S Geiss, Yiling J Cheng, Deborah B Rolka, Desmond E Williams, Carl J Caspersen. Diabetes Care 2013
150
11

Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management.
Susanne Fonville, Adrienne A M Zandbergen, Peter J Koudstaal, Heleen M den Hertog. Cerebrovasc Dis 2014
32
11

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M A Nauck, I Vardarli, C F Deacon, J J Holst, J J Meier. Diabetologia 2011
305
11

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
M B Toft-Nielsen, M B Damholt, S Madsbad, L M Hilsted, T E Hughes, B K Michelsen, J J Holst. J Clin Endocrinol Metab 2001
622
11




The diabetes risk score: a practical tool to predict type 2 diabetes risk.
Jaana Lindström, Jaakko Tuomilehto. Diabetes Care 2003
979
11

Liraglutide prevents diabetes progression in prediabetic OLETF rats.
Nanjing Guo, Jia Sun, Hong Chen, Hua Zhang, Zhen Zhang, Dehong Cai. Endocr J 2013
18
11

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.
Ji Hye Han, Tae Jung Oh, Ghayoung Lee, Hyo Jin Maeng, Dong Hwa Lee, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Hye Seung Lee, Kyong Soo Park,[...]. Diabetologia 2017
106
11

Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistance.
Hideaki Kaneto, Atsushi Obata, Tomohiko Kimura, Masashi Shimoda, Seizo Okauchi, Naoki Shimo, Taka-Aki Matsuoka, Kohei Kaku. J Diabetes 2017
32
11





The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An,[...]. Lancet 2008
921
11

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
Arne Astrup, Stephan Rössner, Luc Van Gaal, Aila Rissanen, Leo Niskanen, Mazin Al Hakim, Jesper Madsen, Mads F Rasmussen, Michael E J Lean. Lancet 2009
624
11

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
11


Preservation of β-cell function: the key to diabetes prevention.
Ralph A DeFronzo, Muhammad A Abdul-Ghani. J Clin Endocrinol Metab 2011
163
11

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
401
11


Liraglutide (Saxenda) for Weight Loss.
J Suzin Whitten. Am Fam Physician 2016
7
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.